Form 4: Globus Medical Director Douglas Robert Andrew Acquires 15,000 Stock Options
SEC Form 4
Director Douglas Robert Andrew acquired 15,000 stock options in Globus Medical, Inc. on January 23, 2025, which will vest on January 1, 2026.
Summary
- On January 23, 2025, Douglas Robert Andrew, a director of Globus Medical Inc., acquired 15,000 stock options.
- The options have an exercise price of $92.42.
- These options will vest on January 1, 2026.
- The options expire on January 23, 2035.
- The transaction was reported on March 28, 2025.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, indicating a standard stock option grant. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock option grants to a company director, which is a common practice in publicly traded companies to align management's interests with those of shareholders.
Stakeholder Impact
- The stock option grant aligns the director's interests with those of shareholders, potentially incentivizing actions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 01/23/2025 | Date of transaction: Director acquired 15,000 stock options. |
| 01/01/2026 | Vesting date for the acquired stock options. |
| 01/23/2035 | Expiration date for the acquired stock options. |
| 03/28/2025 | Date of filing the Form 4. |
Keywords
stock options, Form 4, Globus Medical, GMED, director, beneficial ownership, Douglas Robert Andrew
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.